Pacific Edge Limited (PFGTF) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pacific Edge Limited reports a steady performance for the six months ending in September 2024, despite challenges posed by Medicare uncertainties. The company’s operating revenue increased slightly, with promising developments in securing Medicare coverage for its Cxbladder tests and advancing new product launches. With a strong cash reserve, Pacific Edge remains focused on maintaining profitability and expanding its market presence.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.
